Total Payments
$16,923
2024 Payments
$3,468
Companies
45
Transactions
627
Medicare Patients
497
Medicare Billing
$62,595
Payment Breakdown by Category
Food & Beverage$14,263 (84.3%)
Other$2,400 (14.2%)
Education$260.70 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,263 | 621 | 84.3% |
| Honoraria | $2,400 | 2 | 14.2% |
| Education | $260.70 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,115 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,557 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,424 | 65 | $0 (2024) |
| R-PHARM US LLC | $1,350 | 3 | $0 (2020) |
| Seattle Genetics, Inc. | $1,278 | 2 | $0 (2017) |
| Amgen Inc. | $1,037 | 36 | $0 (2024) |
| PBG PUERTO RICO LLC | $1,020 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $802.51 | 39 | $0 (2024) |
| ABBVIE INC. | $729.83 | 27 | $0 (2024) |
| Eli Lilly Export S.A. Puerto Rico Branch | $635.88 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,468 | 141 | E.R. Squibb & Sons, L.L.C. ($444.41) |
| 2023 | $3,729 | 165 | E.R. Squibb & Sons, L.L.C. ($518.56) |
| 2022 | $3,602 | 166 | E.R. Squibb & Sons, L.L.C. ($563.72) |
| 2021 | $1,996 | 101 | E.R. Squibb & Sons, L.L.C. ($356.74) |
| 2020 | $1,684 | 22 | R-PHARM US LLC ($1,326) |
| 2019 | $328.57 | 10 | Janssen Pharmaceuticals, Inc ($112.63) |
| 2018 | $499.57 | 11 | Amgen Inc. ($235.00) |
| 2017 | $1,616 | 11 | Seattle Genetics, Inc. ($1,278) |
All Payment Transactions
627 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE, JAKAFI | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Oncology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PBG PUERTO RICO LLC | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug), RYBREVANT, AKEEGA | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: BioOncology | ||||||
| 11/04/2024 | PBG PUERTO RICO LLC | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Janssen Pharmaceuticals, Inc | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 10/23/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $26.80 | General |
| Category: Prostate cancer | ||||||
| 10/15/2024 | Bayer Puerto Rico Inc. | Nubeqa (Drug), Stivarga, Vitrakvi | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 10/10/2024 | PBG PUERTO RICO LLC | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI, JAKAFI | Food and Beverage | Cash or cash equivalent | $18.79 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/07/2024 | PBG PUERTO RICO LLC | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 113 | 214 | $20,020 | $13,478 |
| 2022 | 3 | 137 | 272 | $26,015 | $17,901 |
| 2021 | 4 | 170 | 371 | $30,492 | $22,628 |
| 2020 | 2 | 77 | 138 | $11,803 | $8,587 |
Total Patients
497
Total Services
995
Medicare Billing
$62,595
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 180 | $16,473 | $11,033 | 67.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,176 | $1,464 | 67.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 21 | $1,371 | $981.38 | 71.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 219 | $20,317 | $13,969 | 68.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $3,179 | $2,120 | 66.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 34 | $2,520 | $1,812 | 71.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 245 | $22,694 | $16,891 | 74.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $4,684 | $3,545 | 75.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 17 | 27 | $2,001 | $1,601 | 80.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2021 | 12 | 71 | $1,113 | $591.46 | 53.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 123 | $9,294 | $6,803 | 73.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $2,509 | $1,784 | 71.1% |
About Dr. Luis Acaba, M.D
Dr. Luis Acaba, M.D is a Hematology & Oncology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225031396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Acaba, M.D has received a total of $16,923 in payments from pharmaceutical and medical device companies, with $3,468 received in 2024. These payments were reported across 627 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,263).
As a Medicare-enrolled provider, Acaba has provided services to 497 Medicare beneficiaries, totaling 995 services with total Medicare billing of $62,595. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location San Juan, PR
- Active Since 05/23/2005
- Last Updated 12/12/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1225031396
Products in Payments
- IXEMPRA (Drug) $1,326
- OPDIVO (Biological) $1,116
- KEYTRUDA (Biological) $760.40
- IBRANCE (Drug) $717.82
- DARZALEX (Biological) $520.40
- VENCLEXTA (Drug) $511.12
- REBLOZYL (Biological) $474.45
- ERLEADA (Drug) $450.48
- TAGRISSO (Drug) $378.69
- LUMAKRAS (Drug) $366.87
- VERZENIO (Drug) $339.18
- IMBRUVICA (Drug) $331.97
- LYNPARZA (Drug) $330.11
- Pomalyst (Drug) $329.52
- SARCLISA (Biological) $321.98
- Lenvima (Drug) $299.76
- KISQALI (Drug) $264.38
- NERLYNX (Drug) $262.20
- MONJUVI (Drug) $253.06
- ADCETRIS (Biological) $250.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in San Juan
Mr. Jose Lozada Costas, Md, MD
Hematology & Oncology — Payments: $303,725
Hematology & Oncology $303,725
Dr. Noridza Rivera-Rodriguez
Hematology & Oncology — Payments: $185,409
Hematology & Oncology $185,409
Dr. Fernado Cabanillas, Md, MD
Hematology & Oncology — Payments: $70,603
Hematology & Oncology $70,603
Dr. Luis Delgado Mateu
Hematology & Oncology — Payments: $62,607
Hematology & Oncology $62,607
Sixto Perez Garcia, Md, MD
Hematology & Oncology — Payments: $58,973
Hematology & Oncology $58,973
Dr. Armando Garcia, M.d, M.D
Hematology & Oncology — Payments: $37,925
Hematology & Oncology $37,925